Phytomedicine
Volume 16, Issue 2 , Pages 258-261 , March 2009

Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity

  • A. Kato

      Affiliations

    • Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan
    • Corresponding Author InformationCorresponding author. Fax: +81764345155.
  • ,
  • H. Yasuko

      Affiliations

    • Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan
  • ,
  • H. Goto

      Affiliations

    • Department of Kampo Diagnostics, Institute of Natural Medicine, Toyama 930-0194, Japan
  • ,
  • J. Hollinshead

      Affiliations

    • Institute of Grassland and Environmental Research, Plas Gogerddan, Aberystwyth, Ceredigion SY23 3EB, UK
  • ,
  • R.J. Nash

      Affiliations

    • Institute of Grassland and Environmental Research, Plas Gogerddan, Aberystwyth, Ceredigion SY23 3EB, UK
  • ,
  • I. Adachi

      Affiliations

    • Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan

References 

  1. Battinelli L, Mengoni F, Lichtner M, Mazzanti G, Saija A, Mastroianni CM, et al. Effect of limonin and nomilin on HIV-1 replication on infected human mononuclear cells. Planta. Med. 2003;69:910–913
  2. Cappiello M, Voltarelli M, Giannessi M, Cecconi I, Camici G, Manao G, et al. Glutathione dependent modification of bovine lends aldose reductase. Exp. Eye. Res. 1994;58:491–501
  3. Choi YH, Shin EM, Kim YS, Cai XF, Lee JJ, Kim HP. Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms. Arch. Pharm. Res. 2006;29:293–297
  4. Clements RS, Morrison AD, Winegrad AI. Polyol pathway in aorta: regulation by hormones. Science. 1969;166:1007–1008
  5. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. 2000;58(Suppl. 77):S-3–S-12
  6. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38:1203–1206
  7. Frank RN, Keirn RJ, Kennedy A, Frank KW. Galactose-induced retinal capillary basement membrane thickening: prevention by sorbinil. Invest. Ophthalmol. Vis. Sci. 1983;24:1519–1524
  8. Haraguchi H, Ohmi I, Fukuda A, Tamura Y, Mizutani K, Tanaka O, et al. Inhibition aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis. Biosci. Biotechnol. Biochem. 1997;61:651–654
  9. Hotta N, Kakuta H, Fukasawa H, Kimura M, Koh N, Iida M, et al. Effect of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. Diabetologia. 1985;28:176–180
  10. Iimura M, Tanaka T, Mizuo M, Katsuzaki T, Ogawa H. Structure–activity correlation of flavonoids for inhibition of bovine lens aldose reductase. Chem. Pharm. Bull. 1989;37:1813–1815
  11. Jakobs S, Fridrich D, Hofem S, Paflke G, Eisenbrand G. Natural flavonoids are potent inhibitors of glycogen phosphorylase. Mol. Nutr. Food Res. 2006;50:52–57
  12. Joshi B, Puar M, Moore M, Plletier W. Isolation of dihydroavicine and rhetsinine from Zanthoxylum Budrunga. The revision of 1H and 13C NMR spectral assignments for sanguinarine. Heterocycles. 1991;32:1365–1370
  13. Kawanishi K, Ueda H, Moriyasu M. Aldose reductase inhibitors from nature. Curr. Med. Chem. 2003;10:1353–1374
  14. Kinoshita JH. Mechanisms initiating cataract formation. Invest. Invest. Ophthalmol. 1974;13:713–724
  15. Malone JI, Knox G, Benford S, Tedesco TA. Red cell sorbitol: an inhibitor of diabetic control. Diabetes. 1980;29:861–864
  16. Malone JI, Leavengood H, Peterson MJ, O’brien MM, Page MG, Aldinger CE. Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects. Diabetes. 1984;33:45–49
  17. Matsuda H, Morikawa T, Toguchida I, Yoshikawa M. Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. 2002;50:788–795
  18. McDougall GJ, Stewart D. The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors. 2005;23:189–195
  19. Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M. Inhibition of aldose reductases from rat and bovine lenses by flavonoids. Biochem. Pharmacol. 1982;31:3807–3822
  20. Robinson WG, Kador JP, Kinoshita JH. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science. 1983;221:1177–1178
  21. Robinson WG, Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabetic-like retinopathy in rat prevented with an aldose reductase Inhibitor. Invest. Ophthalmol. Vis. Sci. 1989;30:2285–2292
  22. Wang C, Wang MW, Tashiro S, Onodera S, Ikejima T. Evodiamine induced human melanoma A375-S2 cell death partially through interleukin 1 mediated pathway. Biol. Pharm. Bull. 2005;28:984–989
  23. Wang L, Hu CP, Deng PY, Shen SS, Zhu HQ, Ding JS, et al. The protective effects of rutaecarpine on gastric mucosa injury in rat. Planta. Med. 2005;71:416–419
  24. Winegrad AI. Does a common mechanism induce the diverse complications of diseases?. Diabetes. 1987;36:396–405
  25. Young RJ, Ewing DJ, Clarke BF. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes. 1983;32:938–942

PII: S0944-7113(07)00072-4

doi: 10.1016/j.phymed.2007.04.008

Phytomedicine
Volume 16, Issue 2 , Pages 258-261 , March 2009